94% accuracy: INOVIQ’s game-changing ovarian cancer test
INOVIQ (ASX:IIQ) has announced a breakthrough in detecting ovarian cancer. The results are a step forward toward earlier detection of the disease, and early intervention is known to dramatically improve survival rates. There are no current recommended screening methods for asymptomatic women. The global market for ovarian cancer diagnostics was valued at $1.7bn in 2023, […]
94% accuracy: INOVIQ’s game-changing ovarian cancer test Read More »